<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1213" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1213/" /><meta name="ncbi_pagename" content="FLNA-Related Periventricular Nodular Heterotopia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>FLNA-Related Periventricular Nodular Heterotopia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="FLNA-Related Periventricular Nodular Heterotopia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/09/17" /><meta name="citation_author" content="Ming Hui Chen" /><meta name="citation_author" content="Christopher A Walsh" /><meta name="citation_pmid" content="20301392" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1213/" /><meta name="citation_keywords" content="X-Linked Periventricular Heterotopia" /><meta name="citation_keywords" content="Bilateral Periventricular Nodular Heterotopia (BPNH)" /><meta name="citation_keywords" content="X-Linked Periventricular Heterotopia" /><meta name="citation_keywords" content="Filamin-A" /><meta name="citation_keywords" content="FLNA" /><meta name="citation_keywords" content="FLNA-Related Periventricular Nodular Heterotopia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="FLNA-Related Periventricular Nodular Heterotopia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ming Hui Chen" /><meta name="DC.Contributor" content="Christopher A Walsh" /><meta name="DC.Date" content="2015/09/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1213/" /><meta name="description" content="FLNA-related periventricular nodular heterotopia (PVNH), a neuronal migration disorder, is characterized by the presence of uncalcified nodules of neurons ectopically situated along the surface of the lateral ventricles. Affected individuals are predominantly heterozygous females; males most often show early lethality. Affected females present with seizures at an average age of 14-15 years; intelligence ranges from normal to borderline. The risk for cardiovascular disease, stroke, and other vascular/coagulation problems appears to be increased." /><meta name="og:title" content="FLNA-Related Periventricular Nodular Heterotopia" /><meta name="og:type" content="book" /><meta name="og:description" content="FLNA-related periventricular nodular heterotopia (PVNH), a neuronal migration disorder, is characterized by the presence of uncalcified nodules of neurons ectopically situated along the surface of the lateral ventricles. Affected individuals are predominantly heterozygous females; males most often show early lethality. Affected females present with seizures at an average age of 14-15 years; intelligence ranges from normal to borderline. The risk for cardiovascular disease, stroke, and other vascular/coagulation problems appears to be increased." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1213/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/x-pvh/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1213/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B959CE0402421000000000711027E.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1213_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1213_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fkbp14-keds/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/flnb-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1213_"><span class="title" itemprop="name"><i>FLNA</i>-Related Periventricular Nodular Heterotopia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: X-Linked Periventricular Heterotopia</div><p class="contrib-group"><span itemprop="author">Ming Hui Chen</span>, MD, MSc and <span itemprop="author">Christopher A Walsh</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1213_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1213_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ming Hui Chen</span>, MD, MSc<div class="affiliation small">Boston Children's Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.notsobhc.oidrac@nehc.iuhgnim" class="oemail">gro.notsobhc.oidrac@nehc.iuhgnim</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Christopher A Walsh</span>, MD, PhD<div class="affiliation small">Boston Children's Hospital<br />Howard Hughes Medical Institute<br />Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@hslaw.rehpotsirhc" class="oemail">ude.dravrah.snerdlihc@hslaw.rehpotsirhc</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 8, 2002</span>; Last Update: <span itemprop="dateModified">September 17, 2015</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="x-pvh.Summary" itemprop="description"><h2 id="_x-pvh_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>FLNA</i>-related periventricular nodular heterotopia (PVNH), a neuronal migration disorder, is characterized by the presence of uncalcified nodules of neurons ectopically situated along the surface of the lateral ventricles. Affected individuals are predominantly <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females; males most often show early lethality. Affected females present with seizures at an average age of 14-15 years; intelligence ranges from normal to borderline. The risk for cardiovascular disease, stroke, and other vascular/coagulation problems appears to be increased.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>FLNA</i>-related PVNH is established by the identification of:</p><ul><li class="half_rhythm"><div>Characteristic head MRI findings; and</div></li><li class="half_rhythm"><div>Heterozygous pathogenic variants in <i>FLNA</i> in females or <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> pathogenic variants in <i>FLNA</i> in males.</div></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment of epilepsy generally follows principles for a seizure disorder caused by a known structural brain abnormality. Antiepileptic drugs are typically selected based on specific attributes (e.g., teratogenic risk during pregnancy, tolerability, and efficacy). Because of the risk for aortic or carotid dissection, it may also be wise to ensure good blood pressure control. Standard treatment for aortic or carotid dissection, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, and valvular disease.</p><p><i>Surveillance:</i> Echocardiogram and cardiac MRI may be used to screen for <i>FLNA</i>-associated cardiovascular problems. Special attention should be paid to the presence of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, valvular abnormalities, and also dilatation of the ascending aorta.</p><p><i>Evaluation of relatives at risk</i>: Given the risk for vascular disease in neurologically asymptomatic individuals, it is appropriate to evaluate the older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p><p><i>Pregnancy management</i>: The teratogenic risk to the fetus associated with the use of anti-seizure medication during pregnancy depends on the type of anti-seizure medication used, the dose, and the gestational age of the fetus. There are currently no guidelines regarding the most appropriate surveillance for and management of cardiac, vascular, and connective tissue problems during pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>FLNA</i>-related PVNH is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. The condition is prenatally or neonatally lethal in most males; therefore, the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are female. About 50% of affected females inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from their mother and at least 50% have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant. For women with <i>FLNA</i>-related PVNH, the risk of passing the pathogenic variant to each child is 50%. Because of the high rate of prenatal lethality in males, most sons born to women with <i>FLNA</i>-related PVNH are unaffected. Prenatal diagnosis by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is possible if the pathogenic variant has been identified in an affected relative. Periventricular nodules may be visualized by imaging as early as 24 weeks' gestation; however, the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of imaging for the prenatal detection of PVNH is not known.</p></div></div><div id="x-pvh.Diagnosis"><h2 id="_x-pvh_Diagnosis_">Diagnosis</h2><div id="x-pvh.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>FLNA</i>-related periventricular nodular heterotopia (PVNH) <b>should be suspected</b> in an individual with the following clinical features, neuroimaging studies, and family history.</p><p><b>Clinical findings.</b> No clinical findings are diagnostic. Affected individuals typically have seizures and normal intellect.</p><p><b>Neuroimaging studies</b> reviewed by an experienced neuroradiologist reveal the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">On MRI, bilateral, nearly contiguous periventricular nodular heterotopia (ectopic collections of neurons) lining the lateral ventricles beneath an otherwise normal-appearing cortex; occasionally, mild abnormalities of cerebral cortical gyri</div><div class="half_rhythm">Note: CT does not allow visualization of brain structures as clearly as MRI; therefore, heterotopia may be missed by CT imaging.</div></li><li class="half_rhythm"><div class="half_rhythm">Thinning of the corpus callosum and malformations of the posterior fossa (mild cerebellar hypoplasia, enlarged cisterna magna) in some (see <a class="figpopup" href="/books/NBK1213/figure/x-pvh.F1/?report=objectonly" target="object" rid-figpopup="figxpvhF1" rid-ob="figobxpvhF1">Figure 1</a>)</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figxpvhF1" co-legend-rid="figlgndxpvhF1"><a href="/books/NBK1213/figure/x-pvh.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figxpvhF1" rid-ob="figobxpvhF1"><img class="small-thumb" src="/books/NBK1213/bin/x-pvh-Image001.gif" src-large="/books/NBK1213/bin/x-pvh-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndxpvhF1"><h4 id="x-pvh.F1"><a href="/books/NBK1213/figure/x-pvh.F1/?report=objectonly" target="object" rid-ob="figobxpvhF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Anatomic phenotype of PVNH in an individual with a heterozygous pathogenic variant in FLNA A. MRI of the head demonstrating characteristic periventricular nodular heterotopia</p></div></div><p><b>Family history</b> consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance with male lethality is strongly suggestive.</p></div><div id="x-pvh.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of <i>FLNA</i>-related PVNH <b>is established</b> in a female proband by the identification of characteristic head MRI findings and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNA</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1213/table/x-pvh.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figxpvhTmoleculargenetictestingusedi" rid-ob="figobxpvhTmoleculargenetictestingusedi">Table 1</a>).</p><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males typically show male lethality; however the diagnosis of <i>FLNA</i>-related PVNH <b>is established</b> in a male proband by the identification of characteristic head MRI findings and a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNA</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1213/table/x-pvh.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figxpvhTmoleculargenetictestingusedi" rid-ob="figobxpvhTmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>FLNA</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>FLNA</i> and other genes of interest (see <a href="#x-pvh.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="x-pvh.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>FLNA</i>-Related Periventricular Nodular Heterotopia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1213/table/x-pvh.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-pvh.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_x-pvh.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_x-pvh.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_x-pvh.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_x-pvh.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLNA</i></td><td headers="hd_h_x-pvh.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_x-pvh.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">93%&#x000a0;<sup>5,&#x000a0;6</sup></td></tr><tr><td headers="hd_h_x-pvh.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> / <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>7</sup></td><td headers="hd_h_x-pvh.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/33&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="x-pvh.TF.1.1"><p class="no_margin">See <a href="/books/NBK1213/#x-pvh.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="x-pvh.TF.1.2"><p class="no_margin">See <a href="#x-pvh.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="x-pvh.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="x-pvh.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="x-pvh.TF.1.5"><p class="no_margin">93% (8/8 [<a class="bk_pop" href="#x-pvh.REF.parrini.2006.1892">Parrini et al 2006</a>] and 5/6 [<a class="bk_pop" href="#x-pvh.REF.sheen.2001.1775">Sheen et al 2001</a>]) for individuals with classic bilateral PVNH and an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance pattern. 93% of individuals with a <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were female and 7% were male.</p></div></dd><dt>6. </dt><dd><div id="x-pvh.TF.1.6"><p class="no_margin">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA cannot detect <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female.</p></div></dd><dt>7. </dt><dd><div id="x-pvh.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>8. </dt><dd><div id="x-pvh.TF.1.8"><p class="no_margin">Of 33 individuals with PVNH and a family history of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance who were not found to have an <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> rearrangements were identified in three [<a class="bk_pop" href="#x-pvh.REF.clapham.2012.269">Clapham et al 2012</a>].</p></div></dd></dl></div></div></div></div></div><div id="x-pvh.Clinical_Characteristics"><h2 id="_x-pvh_Clinical_Characteristics_">Clinical Characteristics</h2><div id="x-pvh.Clinical_Description"><h3>Clinical Description</h3><p><i>FLNA</i>-related periventricular nodular heterotopia (PVNH) is prenatally or neonatally lethal in most males; therefore, the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are female.</p><p>The following clinical features have been associated with <i>FLNA</i>-related PVNH:</p><ul><li class="half_rhythm"><div>Seizure disorder</div></li><li class="half_rhythm"><div>Cardiovascular findings including patent ductus arteriosus; dilatation and rupture of the thoracic aorta; atrial and ventricular septal defects; valvular dystrophy; and vasculopathy and/or coagulopathy leading to stroke</div></li><li class="half_rhythm"><div>Congenital strabismus</div></li><li class="half_rhythm"><div>Shortened digits</div></li><li class="half_rhythm"><div>Hyperflexible joints [<a class="bk_pop" href="#x-pvh.REF.sheen.2005.254">Sheen et al 2005</a>]</div></li><li class="half_rhythm"><div>Dyslexia</div></li></ul><p><b>Seizure disorder.</b> Approximately 88% of individuals diagnosed with <i>FLNA</i>-related PVNH present with a seizure disorder [<a class="bk_pop" href="#x-pvh.REF.guerrini.2001.532">Guerrini &#x00026; Carrozzo 2001</a>]. Age of onset may be within the first years of life, but more typically individuals present during childhood. The severity of the seizure disorder may range from mild (with rare frequency and remission without need of antiepileptic drugs) to intractable seizures.</p><p>No correlation exists between the extent and severity of the nodular heterotopia seen radiographically and the clinical manifestations. The ectopic heterotopias act as foci for abnormal neuronal activity. Anatomic studies have shown aberrant projections extending from the periventricular heterotopias. Depth electrode recordings have demonstrated epileptogenic discharges from these nodules [<a class="bk_pop" href="#x-pvh.REF.kothare.1998.1723">Kothare et al 1998</a>]. Thus, the seizure disorder appears to arise from the heterotopias in most individuals.</p><p><b>Cardiovascular findings.</b> Over the last decade there have been reports of several serious cardiovascular anomalies in individuals with <i>FLNA</i>-related PVNH. The most important abnormality is thoracic aortic dilatation or aneurysm formation that may lead to sudden aortic rupture or dissection [<a class="bk_pop" href="#x-pvh.REF.feng.2004.1034">Feng &#x00026; Walsh 2004</a>].</p><p>In a study examining cardiovascular lesions in a cohort of individuals with PVNH, five of the six individuals with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (female) or <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> (male) pathogenic variants in <i>FLNA</i> had one or more cardiac anomaly. Lesions included patent ductus arteriosus, thoracic aortic aneurysm, atrial septal defect, ventricular septal defect, and dysplasia of the mitral and aortic valves [<a class="bk_pop" href="#x-pvh.REF.de_wit.2011.45">de Wit et al 2011</a>] (see <a href="#x-pvh.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</a>).</p><p>A study of a family in which five males had <i>FLNA</i>-related PVNH found that four of the five boys had one or more cardiovascular diagnoses (PDA in 2, ASD in 1, dysplastic mitral valve in 2), demonstrating that not all males with <i>FLNA</i>-related PVNH die during the perinatal period [<a class="bk_pop" href="#x-pvh.REF.oegema.2013.2376">Oegema et al 2013</a>].</p><p>Some individuals with <i>FLNA</i>-related PVNH display connective tissue and vascular anomalies also seen in <a href="/books/n/gene/eds/">classic Ehlers-Danlos syndrome</a> [<a class="bk_pop" href="#x-pvh.REF.sheen.2005.254">Sheen et al 2005</a>]. In a recent review of the vascular and connective tissue anomalies associated with pathogenic variants in <i>FLNA</i>, ten of the eleven <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals showed one or more <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cardiac or vascular anomalies. In this particular study, thoracic aortic aneurysm emerged as the most frequent lesion &#x02013; a significant finding given its potential lethality [<a class="bk_pop" href="#x-pvh.REF.reinstein.2013.494">Reinstein et al 2013</a>]. Such anomalies include joint hypermobility, aortic dilation and other vascular anomalies, and nodular brain heterotopias. Increasingly, the Ehlers-Danlos variant of PVNH is considered to fall within the spectrum of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> PVNH caused by pathogenic variants in <i>FLNA</i> [<a class="bk_pop" href="#x-pvh.REF.reinstein.2013.494">Reinstein et al 2013</a>].</p><p><b>Pulmonary findings.</b> There are several case reports of individuals with <i>FLNA</i>-related PVNH who have pulmonary disease. Several reported individuals(both male and female) had cardiorespiratory failure before age one year. The severity of the poorly defined respiratory disease, resembling bronchopulmonary dysplasia, has led to lung transplantation in several of these young children [<a class="bk_pop" href="#x-pvh.REF.masurelpaulet.2011.25">Masurel-Paulet et al 2011</a>, <a class="bk_pop" href="#x-pvh.REF.clapham.2012.269">Clapham et al 2012</a>, <a class="bk_pop" href="#x-pvh.REF.lord.2014.e171">Lord et al 2014</a>].</p><p><b>Other.</b> Other associated clinical findings in individuals with <i>FLNA</i>-related PVNH included gastric immotility (1/11), strabismus (2/11), and shortened digits (1/11).</p><p>Note: Immune compromise with recurrent infection was reported in two of the individuals in the initial report, but immune compromise has not been seen in any other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual; therefore, the association with PVNH is unknown.</p><p>Intelligence is normal to borderline. Formal cognitive testing of 12 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <i>FLNA</i> pathogenic variants demonstrated an average IQ of 95, but also a strikingly high number of affected people with dyslexia [<a class="bk_pop" href="#x-pvh.REF.chang.2005.799">Chang et al 2005</a>, <a class="bk_pop" href="#x-pvh.REF.chang.2007.2146">Chang et al 2007</a>].</p><p>Women with <i>FLNA</i>-related PVNH may have an increased incidence of pregnancy loss as a result of spontaneous abortion of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male pregnancies.</p><p><b>Affected males.</b> Two <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> males (<a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males with no family history of PVNH) with documented <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>FLNA</i> pathogenic variants presented with seizures. One of the males died from sudden rupture of the aorta at age 36 years [<a class="bk_pop" href="#x-pvh.REF.sheen.2001.1775">Sheen et al 2001</a>].</p><p>Five other males ranging in age from five days to five months died suddenly and unexpectedly; while their deaths were consistent with sudden cardiovascular or hematologic collapse, the actual causes of death were unknown [<a class="bk_pop" href="#x-pvh.REF.parrini.2004.191">Parrini et al 2004</a>, <a class="bk_pop" href="#x-pvh.REF.parrini.2006.1892">Parrini et al 2006</a>].</p><p>A single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male with a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> complete <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant in <i>FLNA</i> also showed overwhelming hemorrhage and arrested myeloid and erythroid bone marrow development [<a class="bk_pop" href="#x-pvh.REF.huttenlocher.1994.51">Huttenlocher et al 1994</a>].</p><p>Two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> dizygotic twin males have been reported, one with early death, the other with intellectual disability but not epilepsy [<a class="bk_pop" href="#x-pvh.REF.g_rardblanluet.2006.1041">G&#x000e9;rard-Blanluet et al 2006</a>].</p><p><b>Mosaicism.</b> Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for an A&#x0003e;G substitution at the <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 11 acceptor <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> was reported by <a class="bk_pop" href="#x-pvh.REF.parrini.2004.191">Parrini et al [2004]</a> in a male with bilateral PVNH. Sequence analysis and denaturing high-performance liquid chromatography of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA on a pool of hair roots, single hair roots, and white blood cells revealed that only 42% and 69% of the samples for hair and blood, respectively, had the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Moreover, the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male's daughter did not inherit the pathogenic variant, thought to be causal for the male <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Other somatic pathogenic variants were recently reported [<a class="bk_pop" href="#x-pvh.REF.jamuar.2014.733">Jamuar et al 2014</a>].</p><p>Note: Although three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> brothers with West syndrome/hypsarrhythmia were initially reported to have a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#x-pvh.REF.masruha.2006.211">Masruha et al 2006</a>] this reported sequence variant has subsequently been thought to be a rare <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> [<a class="bk_pop" href="#x-pvh.REF.robertson.2006.1082">Robertson 2006</a>].</p></div><div id="x-pvh.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>All individuals known to have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (female) or <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> (male) <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, including those who are asymptomatic, have heterotopia identifiable by brain MRI or CT [<a class="bk_pop" href="#x-pvh.REF.fox.1998.1315">Fox et al 1998</a>, <a class="bk_pop" href="#x-pvh.REF.poussaint.2000.748">Poussaint et al 2000</a>, <a class="bk_pop" href="#x-pvh.REF.sheen.2001.1775">Sheen et al 2001</a>, <a class="bk_pop" href="#x-pvh.REF.moro.2002.916">Moro et al 2002</a>].</p><p>While more studies correlating <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are needed, pathogenic truncation variants tend to cluster near the N-terminal and presumably lead to severe loss of function and a more severe phenotype (male lethality). Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are found throughout the extent of <i>FLNA</i> and some appear to have milder phenotypes, as males with these pathogenic variants can survive to term. Presumably, these milder pathogenic variants lead to a partially functional protein [<a class="bk_pop" href="#x-pvh.REF.sheen.2001.1775">Sheen et al 2001</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> pathogenic <i>FLNA</i> splice variant has been associated with PVNH, facial dysmorphism, and severe constipation [<a class="bk_pop" href="#x-pvh.REF.hehr.2006.541">Hehr et al 2006</a>].</p></div><div id="x-pvh.Penetrance"><h3>Penetrance</h3><p>Penetrance is unknown. All individuals with known deleterious <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>FLNA</i> variants have shown periventricular nodular heterotopia.</p></div><div id="x-pvh.Nomenclature"><h3>Nomenclature</h3><p>Frequently used terms are periventricular heterotopia (PVH or PH) or periventricular nodular heterotopia (PNH or PVNH).</p></div><div id="x-pvh.Prevalence"><h3>Prevalence</h3><p>The prevalence of PVNH is difficult to assess because individuals with the mild <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may never seek medical evaluation.</p></div></div><div id="x-pvh.Genetically_Related_Allelic_Disord"><h2 id="_x-pvh_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><a href="/books/n/gene/opd/"><b>Otopalatodigital spectrum disorders</b></a><b>.</b> Four other phenotypes associated with pathogenic variants in <i>FLNA</i> are characterized primarily by skeletal dysplasia and are termed the otopalatodigital spectrum disorders [<a class="bk_pop" href="#x-pvh.REF.robertson.2003.487">Robertson et al 2003</a>]. They include:</p><ul><li class="half_rhythm"><div>Otopalatodigital syndrome type I (OPD1)</div></li><li class="half_rhythm"><div>Otopalatodigital syndrome type II (OPD2)</div></li><li class="half_rhythm"><div>Frontometaphyseal dysplasia (FMD)</div></li><li class="half_rhythm"><div>Melnick-Needles syndrome (MNS)</div></li></ul><p>In males, severity ranges from mild manifestations in OPD1 to more severe presentation in FMD and OPD2; prenatal lethality is most common in males with MNS. Females exhibit <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>. In OPD1, most manifestations are present at birth and females can present with severity similar to <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males, but some have only mild manifestations. In OPD2 and FMD, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia that results in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require assistance with feeding and respiratory support. In FMD, males do not experience progression of skeletal dysplasia but may have joint contractures, scoliosis, and hand and feet malformations. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity.</p><p>Periventricular nodular heterotopia is not usually a finding in these phenotypes, and the <i>FLNA</i> pathogenic variants associated with them are felt to be gain of function, whereas those with loss of function likely result in heterotopia formation in the brain.</p><p><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> cardiac valvular dystrophy (XCVD).</b> In males, <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> pathogenic variants in <i>FLNA</i> have been implicated in valvular dysplasia, most commonly resulting in mitral valve prolapse. Dysplasia of all four cardiac valves has been observed [<a class="bk_pop" href="#x-pvh.REF.bernstein.2011.2236">Bernstein et al 2011</a>, <a class="bk_pop" href="#x-pvh.REF.aalberts.2014.113">Aalberts et al 2014</a>]. Heterozygous females are typically unaffected.</p></div><div id="x-pvh.Differential_Diagnosis"><h2 id="_x-pvh_Differential_Diagnosis_">Differential Diagnosis</h2><p>The frequent occurrence of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> or nonfamilial periventricular nodular heterotopia (PVNH) in males and females with no documented <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> suggests that it is a heterogeneous disorder.</p><p>Of 120 females with classic bilateral PVNH who were <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., no family history of PVNH), 31 (26%) had an identifiable <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNA</i>. Overall, <a class="bk_pop" href="#x-pvh.REF.parrini.2006.1892">Parrini et al [2006]</a> found that the probability of identifying an <i>FLNA</i> pathogenic variant in an individual with classic bilateral PVNH was 49% and the probability of identifying an <i>FLNA</i> pathogenic variant in an individual with another <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (e.g., polymicrogyria, microcephaly) was 4%.</p><p>Periventricular nodular heterotopia also occurs in the following syndromes (whether each of these represents a truly distinct disorder or <i>FLNA</i>-related PVNH plus a concurrent condition remains to be determined):</p><ul><li class="half_rhythm"><div>Nonfamilial PVNH caused by perinatal insult or chromosomal rearrangement</div></li><li class="half_rhythm"><div>Autosomal recessive PVNH (OMIM <a href="http://omim.org/entry/608097" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608097</a>). Several families with PVNH consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance have been reported. Biallelic pathogenic variants in <i>ARFGEF2</i> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 20 have been identified in two Turkish families with autosomal recessive PVNH with microcephaly [<a class="bk_pop" href="#x-pvh.REF.sheen.2003a.1108">Sheen et al 2003a</a>, <a class="bk_pop" href="#x-pvh.REF.sheen.2004.69">Sheen et al 2004</a>] and in a female with a movement disorder, neuronal migration disorder, and acquired microcephaly [<a class="bk_pop" href="#x-pvh.REF.de_wit.2009.333">de Wit et al 2009</a>].</div></li><li class="half_rhythm"><div>Autosomal dominant forms of PVNH (OMIM <a href="http://omim.org/entry/608098" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608098</a>) (<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 5p15, 1p36, 7q11) [<a class="bk_pop" href="#x-pvh.REF.sheen.2003b.1033">Sheen et al 2003b</a>, <a class="bk_pop" href="#x-pvh.REF.neal.2006.1692">Neal et al 2006</a>, <a class="bk_pop" href="#x-pvh.REF.ferland.2009.497">Ferland et al 2009</a>]</div></li><li class="half_rhythm"><div>Bilateral periventricular nodular heterotopia (BPNH)/frontonasal malformations (OMIM <a href="http://omim.org/entry/300049" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300049</a>) [<a class="bk_pop" href="#x-pvh.REF.guerrini.1998.499">Guerrini &#x00026; Dobyns 1998</a>]</div></li><li class="half_rhythm"><div>PVNH (unilateral/ bilateral and <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a>) in two boys with fragile X syndrome [<a class="bk_pop" href="#x-pvh.REF.moro.2006.713">Moro et al 2006</a>]</div></li><li class="half_rhythm"><div>BPNH with micronodules</div></li><li class="half_rhythm"><div>BPNH with ambiguous genitalia</div></li><li class="half_rhythm"><div>BPNH with microcephaly</div></li><li class="half_rhythm"><div>BPNH/intellectual disability/syndactyly [<a class="bk_pop" href="#x-pvh.REF.dobyns.1997.1042">Dobyns et al 1997</a>]</div></li><li class="half_rhythm"><div>BPNH/nephrosis syndrome</div></li><li class="half_rhythm"><div>BPNH/short gut syndrome</div></li><li class="half_rhythm"><div>Unilateral PVNH</div></li><li class="half_rhythm"><div>Bilateral anterior PVNH with fronto-perisylvian polymicrogyria [<a class="bk_pop" href="#x-pvh.REF.parrini.2006.1892">Parrini et al 2006</a>]</div></li><li class="half_rhythm"><div>Bilateral PVNH involving temporo-occipital and trigones with hippocampal malformation, and subclassified into polymicrogyria or cerebellar hypoplasia or hydrocephalus [<a class="bk_pop" href="#x-pvh.REF.parrini.2006.1892">Parrini et al 2006</a>]</div></li><li class="half_rhythm"><div>Periventricular nodular heterotopia, intellectual disability, and epilepsy associated with 5q14.3-q15 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (OMIM <a href="http://omim.org/entry/612881" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612881</a>) [<a class="bk_pop" href="#x-pvh.REF.cardoso.2009.784">Cardoso et al 2009</a>]</div></li></ul><p>Laminar heterotopia occurring in deep white matter and band-like heterotopia occurring between the cortex and ventricular surface are seen in <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> subcortical band heterotopia.</p><p>PVNH may be misdiagnosed initially as <a href="/books/n/gene/tuberous-sclerosis/">tuberous sclerosis complex</a>; however, MRI findings distinguish the two disorders.</p></div><div id="x-pvh.Management"><h2 id="_x-pvh_Management_">Management</h2><div id="x-pvh.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>FLNA</i>-related periventricular nodular heterotopia (PVNH) the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Evaluation by a neurologist</div></li><li class="half_rhythm"><div>Evaluation by an epileptologist if seizures are present</div></li><li class="half_rhythm"><div>Magnetic resonance angiography (MRA) of the intracranial vessels, carotid arteries, and aorta to address the increased risk for stroke</div></li><li class="half_rhythm"><div>Echocardiogram or cardiac magnetic resonance imaging (MRA) to evaluate for valvular dysplasia, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cardiac anomalies, or aortic and vascular disease. Because of the potential risk for congenital cardiovascular anomalies and/or aortic aneurysm, a baseline evaluation by a cardiologist may be prudent.</div></li><li class="half_rhythm"><div>Evaluation by a hematologist if findings suggest a bleeding diathesis</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="x-pvh.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management of individuals with <i>FLNA</i>-related PVNH is directed toward symptomatic treatment.</p><p>Treatment of epilepsy generally follows basic principles for a seizure disorder caused by a known structural brain abnormality, including:</p><ul><li class="half_rhythm"><div class="half_rhythm">Detailed initial history and evaluation to confirm the suspicion of a seizure disorder. Testing may include an electroencephalogram (EEG) to define the location and severity of electrical brain dysfunction that may be present in individuals with epilepsy.</div><div class="half_rhythm">Repeat imaging may be necessary only in the setting of new neurologic findings on examination.</div></li><li class="half_rhythm"><div class="half_rhythm">Treatment with antiepileptic agents. Choice of antiepileptics is generally made empirically based on the clinical features of the seizure disorder. However, because no significant differences exist between medications for newly diagnosed, presumably localized epilepsy, choices may be made on the specific attributes of each antiepileptic drug (i.e., risk of teratogenicity of the antiepileptic drug during pregnancy), tolerability, and efficacy.</div></li></ul><p>Because of the risk for aortic or carotid dissection, it may also be wise to ensure good blood pressure control.</p><p>Treatment of aortic/carotid dissection, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, and valvular disease is the same as in the general population.</p><p>Many individuals with periventricular nodular heterotopia have dyslexia. Therefore, it may be prudent for those with a family history of PVNH to have children tested for dyslexia at an early age.</p></div><div id="x-pvh.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>The secondary complications are those associated with prolonged seizure medication usage.</p></div><div id="x-pvh.Surveillance"><h3>Surveillance</h3><p>Because of the associated increased incidence of aortic or carotid dissection in PVNH, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be screened by echocardiogram and cardiac MRI. There is insufficient data at present to provide definitive guidelines. However, given that such complications have occurred in early adulthood, it is reasonable to perform evaluation initially in late adolescence, with follow up as needed. Cardiology evaluation of those who have connective tissue findings and classic PVNH would be prudent.</p></div><div id="x-pvh.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Given the risk for vascular disease in neurologically asymptomatic individuals, it is appropriate to evaluate the older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk relatives.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known, head MRI can be used to clarify the disease status of at-risk relatives.</div></li></ul><p>See <a href="#x-pvh.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="x-pvh.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Ideally, women should seek information prior to conception regarding risks to the fetus associated with taking an anti-seizure medication during pregnancy so that changes in the anti-seizure medication regimen (if needed) can be made prior to conception. If not done prior to conception, discussion of the risks and benefits of anti-seizure medication use during pregnancy should occur as soon as the pregnancy is recognized. The teratogenic risk to the fetus associated with the use of anti-seizure medication during pregnancy depends on the type of anti-seizure medication used, the dose, and the gestational age of the fetus.</p><p>Currently no guidelines exist on the most appropriate surveillance for and management of cardiac, vascular, and connective tissue problems during pregnancy in women with PVNH. See <a href="/books/n/gene/marfan/">Marfan Syndrome</a> and <a href="/books/n/gene/eds/">Ehlers-Danlos Syndrome, Classic Type</a> for possible pregnancy management recommendations.</p></div><div id="x-pvh.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="x-pvh.Other"><h3>Other</h3><p>Surgical resection has been attempted but has not proven beneficial [<a class="bk_pop" href="#x-pvh.REF.li.1997.662">Li et al 1997</a>].</p></div></div><div id="x-pvh.Genetic_Counseling"><h2 id="_x-pvh_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="x-pvh.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>FLNA</i>-related periventricular nodular heterotopia (PVNH) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="x-pvh.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>About 50% of females with <i>FLNA</i>-related PVNH have inherited the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent.</div></li><li class="half_rhythm"><div>If there is only one family member <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with <i>FLNA</i>-related PVNH (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), a parent may have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or the affected child may have a <i>de novo FLNA</i> pathogenic variant. At least 50% of females with <i>FLNA</i>-related PVNH have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, a parent of an affected child has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Note: If a parent has more than one affected child and no other affected relatives and if the pathogenic variant cannot be detected in the parent's leukocyte DNA, the parent has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>Because of variable expression of <i>FLNA</i>-related PVNH, brain MRI should be considered for either parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> if the parent has a history of seizures or learning disabilities. Because very few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have been identified, it is unlikely that the father is affected. All individuals with <i>FLNA</i> pathogenic variants, whether symptomatic or asymptomatic, have nodules identifiable by brain imaging.</div></li></ul><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disease nor will he be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, it is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to the mother.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>If the mother (or, in rare cases, the father) has PVNH and/or an identified <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to a female sib of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> is 50%.</div></li><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has PVNH and/or an identified <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to a male sib of inheriting the <i>FLNA</i> pathogenic variant is 50%; males with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>FLNA</i> pathogenic variants tend to die before birth or soon after birth. Affected males who have survived beyond the neonatal period have been reported; the clinical outcome for an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is uncertain because of the small number of such cases reported.</div></li><li class="half_rhythm"><div>If the mother has no heterotopia identified by brain imaging, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> for future pregnancies is low. Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has not been reported, although this possibility cannot be completely excluded. It is also possible that a child with PVNH and no known family history of the disorder has pathogenic variants in another unidentified <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that could have a different <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>. Therefore, the risk to the sibs of a child with PVNH and no known family history is low but greater than that found in the general population.</div></li></ul><p><b>Offspring of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the offspring of females with MRI or CT findings of PVNH or an identified <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 50%; however, most male conceptuses with PVNH miscarry or die shortly after birth.</div></li><li class="half_rhythm"><div>Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males survive beyond the neonatal period; the clinical outcome for an affected male is uncertain as very few cases have been reported.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>In rare cases, males with <i>FLNA</i> pathogenic variants survive to adulthood and father children.</div></li><li class="half_rhythm"><div>All male offspring of males with <i>FLNA</i> pathogenic variants will be healthy noncarriers, whereas all female offspring will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and hence <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The proband's maternal aunts may be at risk of having inherited the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the aunts' offspring, depending on their gender, may be at risk of having inherited the pathogenic variant and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p>Note: Molecular genetic testing may be able to identify the family member in whom a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> arose, information that could help determine genetic risk status of the extended family.</p></div><div id="x-pvh.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#x-pvh.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who have an <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Genetic heterogeneity.</b> Because evidence for genetic heterogeneity of PVNH exists, women with PVNH and no known family history of the disorder should be informed of the possibility that they may have pathogenic variants in a different as-yet-unidentified <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and may be at a low risk of having <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> offspring because of possible <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="x-pvh.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Ultrasound examination.</b> Fetal ultrasound is relatively insensitive at detecting PVNH until later in pregnancy. Periventricular nodular heterotopias may be detected by fetal ultrasound examination or MRI as early as 24 weeks' gestation. Fetal MRI is performed at some centers using ultrafast MRI so that sedation is not required to reduce fetal movement. The <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of prenatal imaging for the detection of PVNH is not known. Whether periventricular nodular heterotopias may be detected even earlier in gestation by imaging studies is not known.</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p></div></div><div id="x-pvh.Resources"><h2 id="_x-pvh_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Citizens United for Research in Epilepsy (CURE)</b></div><div><a href="http://www.cureepilepsy.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cureepilepsy.org</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li></ul></div><div id="x-pvh.Molecular_Genetics"><h2 id="_x-pvh_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="x-pvh.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>FLNA-Related Periventricular Nodular Heterotopia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1213/table/x-pvh.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-pvh.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_x-pvh.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_x-pvh.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_x-pvh.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_x-pvh.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_x-pvh.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_x-pvh.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_x-pvh.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2316" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FLNA</i></a></td><td headers="hd_b_x-pvh.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2316" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq28</a></td><td headers="hd_b_x-pvh.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P21333" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Filamin-A</a></td><td headers="hd_b_x-pvh.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/FLNA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNA @ LOVD</a></td><td headers="hd_b_x-pvh.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FLNA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNA</a></td><td headers="hd_b_x-pvh.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FLNA[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNA</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="x-pvh.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="x-pvh.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for FLNA-Related Periventricular Nodular Heterotopia (<a href="/omim/300017,300049" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1213/table/x-pvh.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-pvh.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300017" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300017</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FILAMIN A; FLNA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300049" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300049</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1</td></tr></tbody></table></div></div><div id="x-pvh.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>The filamin class of actin-binding proteins is known to regulate cell stability, protrusion, and motility across various biologic systems [<a class="bk_pop" href="#x-pvh.REF.ott.1998.1241">Ott et al 1998</a>, <a class="bk_pop" href="#x-pvh.REF.leonardi.2000.271">Leonardi et al 2000</a>, <a class="bk_pop" href="#x-pvh.REF.stahlhut.2000.325">Stahlhut &#x00026; van Deurs 2000</a>]. Filamin-deficient melanocytes fail to undergo locomotion in response to factors that elicit migration in the same filamin-expressing cells. They exhibit prolonged circumferential blebbing, abnormal phagocytosis, and impaired volume regulation, perhaps secondary to abnormal regulation of sodium channel activity. Findings suggest that <i>FLNA</i> may have an influence similar to that of integrins, which have been implicated in cell adhesion and neuronal migration [<a class="bk_pop" href="#x-pvh.REF.meyer.1997.2914">Meyer et al 1997</a>, <a class="bk_pop" href="#x-pvh.REF.loo.1998.23304">Loo et al 1998</a>, <a class="bk_pop" href="#x-pvh.REF.dulabon.2000.33">Dulabon et al 2000</a>] on neuroblast migration during cortical development within the central nervous system. Recent studies suggest that genes in which mutation causes PVNH are involved in vesicle trafficking, necessary for delivery of proteins involved in cell adhesion [<a class="bk_pop" href="#x-pvh.REF.ferland.2009.497">Ferland et al 2009</a>]. Disruption of this process likely results in the formation of periventricular nodular heterotopias.</p><p><b>Gene structure.</b>
<i>FLNA</i> comprises 48 exons (reference sequence <a href="/entrez/viewer.fcgi?val=NM_001110556.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001110556.1</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1213/#x-pvh.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants in <i>FLNA</i> identified to date have generally been single nucelotide variants or deletions with presumed loss of function. Each family or individual representing a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) has had a unique <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#x-pvh.REF.sheen.2001.1775">Sheen et al 2001</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Filamin-A encodes a large (280-kd) cytoplasmic actin-binding phosphoprotein that links membrane receptors to the actin cytoskeleton and represents a potentially crucial link between signal transduction and the cytoskeleton. The protein consists of an actin-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> at the amino terminus, 23 repeats that resemble Ig-like domains and form a rod-like structure interrupted by two hinge regions, and a truncated C-terminal repeat that undergoes dimerization and binding to membrane receptors. The reference sequence of the protein isoform encoded by the transcript variant <a href="/entrez/viewer.fcgi?val=NM_001110556.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001110556.1</a> is <a href="/entrez/viewer.fcgi?val=NP_001104026.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001104026.1</a>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> More than 40 documented pathogenic variants in <i>FLNA</i> are protein-truncating or -<a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants, predicted to result in severe loss of function [<a class="bk_pop" href="#x-pvh.REF.walsh.2010.245">Walsh &#x00026; Engle 2010</a>]. Over a dozen <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <i>FLNA</i> variants are associated with PVNH, whereas another dozen or more missense variants are associated with other <i>FLNA</i>-related disorders. Truncation variants occur throughout the length of the protein. Many, though not all, PVNH-associated missense variants occur in the N-terminal actin-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of FNH. Mild to moderate variants, either missense or truncations near the C-terminus, may have milder clinical phenotypes in females and thus avoid detection. Conversely, in males, severe to moderate defects lead to loss of fetal viability, and only partial-<a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants are found in surviving males [<a class="bk_pop" href="#x-pvh.REF.sheen.2001.1775">Sheen et al 2001</a>, <a class="bk_pop" href="#x-pvh.REF.moro.2002.916">Moro et al 2002</a>].</p><p><b>Mouse model.</b> An <i>Flna</i> knockout mouse model demonstrates abnormal embryologic development of the heart and vasculature, including <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> abnormalities of the left-ventricular outflow tract, the atria, the ventricles, and the great vessels of the heart. The vasculature of these <i>Flna</i> knockout mice also demonstrated coarse, dilated, and abnormally branching blood vessels. Furthermore, the blood vessels had abnormal adherens junctions or abnormal cell-to-cell contact [<a class="bk_pop" href="#x-pvh.REF.feng.2006.19836">Feng et al 2006</a>].</p></div></div><div id="x-pvh.References"><h2 id="_x-pvh_References_">References</h2><div id="x-pvh.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.aalberts.2014.113">Aalberts JJ, van Tintelen JP, Oomen T, Bergman JE, Halley DJ, Jongbloed JD, Suurmeijer AJ, van den Berg MP. Screening of TGFBR1, TGFBR2, and FLNA in familial mitral valve prolapse. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:113–9.</span> [<a href="/pubmed/24243761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24243761</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.bernstein.2011.2236">Bernstein JA, Bernstein D, Hehr U, Hudgins L. Familial cardiac valvulopathy due to filamin A mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:2236–41.</span> [<a href="/pubmed/21815255" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21815255</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.cardoso.2009.784">Cardoso C, Boys A, Parrini E, Mignon-Ravix C, McMahon JM, Khantane S, Bertini E, Pallesi E, Missirian C, Zuffardi O, Novara F, Villard L, Giglio S, Chabrol B, Slater HR, Moncla A, Scheffer IE, Guerrini R. Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:784–92.</span> [<a href="/pubmed/19073947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19073947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.chang.2007.2146">Chang BS, Katzir T, Liu T, Corriveau K, Barzillai M, Apse KA, Bodell A, Hackney D, Alsop D, Wong ST, Walsh CA. A structural basis for reading fluency: white matter defects in a genetic brain malformation. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">69</span>:2146–54.</span> [<a href="/pubmed/18056578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18056578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.chang.2005.799">Chang BS, Ly J, Appignani B, Bodell A, Apse KA, Ravenscroft RS, Sheen VL, Doherty MJ, Hackney DB, O'Connor M, Galaburda AM, Walsh CA. Reading impairment in the neuronal migration disorder of periventricular nodular heterotopia. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:799–803.</span> [<a href="/pubmed/15753412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15753412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.clapham.2012.269">Clapham KR, Yu TW, Ganesh VS, Barry B, Chan Y, Mei D, Parrini E, Funalot B, Dupuis L, Nezarati MM, du Souich C, van Karnebeek C, Guerrini R, Walsh CA. FLNA genomic rearrangements cause periventricular nodular heterotopia. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:269–78.</span> [<a href="/pmc/articles/PMC3280053/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3280053</span></a>] [<a href="/pubmed/22238415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22238415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.de_wit.2009.333">de Wit MC, de Coo IF, Halley DJ, Lequin MH, Mancini GM. Movement disorder and neuronal migration disorder due to ARFGEF2 mutation. <span><span class="ref-journal">Neurogenetics. </span>2009;<span class="ref-vol">10</span>:333–6.</span> [<a href="/pmc/articles/PMC2758209/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2758209</span></a>] [<a href="/pubmed/19384555" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19384555</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.de_wit.2011.45">de Wit MC, de Coo IF, Lequin MH, Halley DJ, Roos-Hesselink JW, Mancini GM. Combined cardiological and neurological abnormalities due to filamin A gene mutation. <span><span class="ref-journal">Clin Res Cardiol. </span>2011;<span class="ref-vol">100</span>:45–50.</span> [<a href="/pmc/articles/PMC3022162/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3022162</span></a>] [<a href="/pubmed/20730588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20730588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.dobyns.1997.1042">Dobyns WB, Guerrini R, Czapansky-Beilman DK, Pierpont ME, Breningstall G, Yock DH Jr, Bonanni P, Truwit CL. Bilateral periventricular nodular heterotopia with mental retardation and syndactyly in boys: a new X-linked mental retardation syndrome. <span><span class="ref-journal">Neurology. </span>1997;<span class="ref-vol">49</span>:1042–7.</span> [<a href="/pubmed/9339687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9339687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.dulabon.2000.33">Dulabon L, Olson EC, Taglienti MG, Eisenhuth S, McGrath B, Walsh CA, Kreidberg JA, Anton ES. Reelin binds alpha3beta1 integrin and inhibits neuronal migration. <span><span class="ref-journal">Neuron. </span>2000;<span class="ref-vol">27</span>:33–44.</span> [<a href="/pubmed/10939329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10939329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.feng.2006.19836">Feng Y, Chen MH, Moskowitz IP, Mendonza AM, Vidali L, Nakamura F, Kwiatkowski DJ, Walsh CA, Filamin A. FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:19836–41.</span> [<a href="/pmc/articles/PMC1702530/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1702530</span></a>] [<a href="/pubmed/17172441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17172441</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.feng.2004.1034">Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. <span><span class="ref-journal">Nat Cell Biol. </span>2004;<span class="ref-vol">6</span>:1034–8.</span> [<a href="/pubmed/15516996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15516996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.ferland.2009.497">Ferland RJ, Batiz LF, Neal J, Lian G, Bundock E, Lu J, Hsiao YC, Diamond R, Mei D, Banham AH, Brown PJ, Vanderburg CR, Joseph J, Hecht JL, Folkerth R, Guerrini R, Walsh CA, Rodriguez EM, Sheen VL. Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:497–516.</span> [<a href="/pmc/articles/PMC2722192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2722192</span></a>] [<a href="/pubmed/18996916" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18996916</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.fox.1998.1315">Fox JW, Lamperti ED, Ek&#x0015f;io&#x0011f;lu YZ, Hong SE, Feng Y, Graham DA, Scheffer IE, Dobyns WB, Hirsch BA, Radtke RA, Berkovic SF, Huttenlocher PR, Walsh CA. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. <span><span class="ref-journal">Neuron. </span>1998;<span class="ref-vol">21</span>:1315–25.</span> [<a href="/pubmed/9883725" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9883725</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.g_rardblanluet.2006.1041">G&#x000e9;rard-Blanluet M, Sheen V, Machinis K, Neal J, Apse K, Danan C, Sinico M, Brugi&#x000e8;res P, Mage K, Ratsimbazafy L, Elbez A, Janaud JC, Amselem S, Walsh C, Encha-Razavi F. Bilateral periventricular heterotopias in an X-linked dominant transmission in a family with two affected males. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1041–6.</span> [<a href="/pubmed/16596669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16596669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.guerrini.2001.532">Guerrini R, Carrozzo R. Epileptogenic brain malformations: clinical presentation, malformative patterns and indications for genetic testing. <span><span class="ref-journal">Seizure. </span>2001;<span class="ref-vol">10</span>:532–43.</span> [<a href="/pubmed/11749114" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11749114</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.guerrini.1998.499">Guerrini R, Dobyns WB. Bilateral periventricular nodular heterotopia with mental retardation and frontonasal malformation. <span><span class="ref-journal">Neurology. </span>1998;<span class="ref-vol">51</span>:499–503.</span> [<a href="/pubmed/9710025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9710025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.hehr.2006.541">Hehr U, Hehr A, Uyanik G, Phelan E, Winkler J, Reardon W. A filamin A splice mutation resulting in a syndrome of facial dysmorphism, periventricular nodular heterotopia, and severe constipation reminiscent of cerebro-fronto-facial syndrome. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:541–4.</span> [<a href="/pmc/articles/PMC2564542/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564542</span></a>] [<a href="/pubmed/16299064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16299064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.huttenlocher.1994.51">Huttenlocher PR, Taravath S, Mojtahedi S. Periventricular heterotopia and epilepsy. <span><span class="ref-journal">Neurology. </span>1994;<span class="ref-vol">44</span>:51–5.</span> [<a href="/pubmed/8290091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8290091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.jamuar.2014.733">Jamuar SS, Lam AT, Kircher M, D'Gama AM, Wang J, Barry BJ, Zhang X, Hill RS, Partlow JN, Rozzo A, Servattalab S, Mehta BK, Topcu M, Amrom D, Andermann E, Dan B, Parrini E, Guerrini R, Scheffer IE, Berkovic SF, Leventer RJ, Shen Y, Wu BL, Barkovich AJ, Sahin M, Chang BS, Bamshad M, Nickerson DA, Shendure J, Poduri A, Yu TW, Walsh CA. Somatic mutations in cerebral cortical malformations. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">371</span>:733–43.</span> [<a href="/pmc/articles/PMC4274952/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4274952</span></a>] [<a href="/pubmed/25140959" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25140959</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.kothare.1998.1723">Kothare SV, VanLandingham K, Armon C, Luther JS, Friedman A, Radtke RA. Seizure onset from periventricular nodular heterotopias: depth-electrode study. <span><span class="ref-journal">Neurology. </span>1998;<span class="ref-vol">51</span>:1723–7.</span> [<a href="/pubmed/9855532" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9855532</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.leonardi.2000.271">Leonardi A, Ellinger-Ziegelbauer H, Franzoso G, Brown K, Siebenlist U. Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:271–8.</span> [<a href="/pubmed/10617615" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10617615</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.li.1997.662">Li LM, Dubeau F, Andermann F, Fish DR, Watson C, Cascino GD, Berkovic SF, Moran N, Duncan JS, Olivier A, Leblanc R, Harkness W. Periventricular nodular heterotopia and intractable temporal lobe epilepsy: poor outcome after temporal lobe resection. <span><span class="ref-journal">Ann Neurol. </span>1997;<span class="ref-vol">41</span>:662–8.</span> [<a href="/pubmed/9153529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9153529</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.loo.1998.23304">Loo DT, Kanner SB, Aruffo A. Filamin binds to the cytoplasmic domain of the beta1-integrin. Identification of amino acids responsible for this interaction. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>:23304–12.</span> [<a href="/pubmed/9722563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9722563</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.lord.2014.e171">Lord A, Shapiro AJ, Saint-Martin C, Claveau M, Melan&#x000e7;on S, Wintermark P. Filamin A mutation may be associated with diffuse lung disease mimicking bronchopulmonary dysplasia in premature newborns. <span><span class="ref-journal">Respir Care. </span>2014;<span class="ref-vol">59</span>:e171–7.</span> [<a href="/pubmed/25053830" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25053830</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.masruha.2006.211">Masruha MR, Caboclo LO, Carrete H Jr, Cendes IL, Rodrigues MG, Garzon E, Yacubian EM, Sakamoto AC, Sheen V, Harney M, Neal J, Hill RS, Bodell A, Walsh C, Vilanova LC. Mutation in filamin A causes periventricular heterotopia, developmental regression, and West syndrome in males. <span><span class="ref-journal">Epilepsia. </span>2006;<span class="ref-vol">47</span>:211–4.</span> [<a href="/pubmed/16417552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16417552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.masurelpaulet.2011.25">Masurel-Paulet A, Haan E, Thompson EM, Goizet C, Thauvin-Robinet C, Tai A, Kennedy D, Smith G, Khong TY, Sol&#x000e9; G, Guerineau E, Coupry I, Huet F, Robertson S, Faivre L. Lung disease associated with periventricular nodular heterotopia and an FLNA mutation. <span><span class="ref-journal">Eur J Med Genet. </span>2011;<span class="ref-vol">54</span>:25–8.</span> [<a href="/pubmed/20888935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20888935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.meyer.1997.2914">Meyer SC, Zuerbig S, Cunningham CC, Hartwig JH, Bissell T, Gardner K, Fox JE. Identification of the region in actin-binding protein that binds to the cytoplasmic domain of glycoprotein IBalpha. <span><span class="ref-journal">J Biol Chem. </span>1997;<span class="ref-vol">272</span>:2914–9.</span> [<a href="/pubmed/9006936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9006936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.moro.2002.916">Moro F, Carrozzo R, Veggiotti P, Tortorella G, Toniolo D, Volzone A, Guerrini R. Familial periventricular heterotopia: missense and distal truncating mutations of the FLN1 gene. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">58</span>:916–21.</span> [<a href="/pubmed/11914408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11914408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.moro.2006.713">Moro F, Pisano T, Bernardina BD, Polli R, Murgia A, Zoccante L, Darra F, Battaglia A, Pramparo T, Zuffardi O, Guerrini R. Periventricular heterotopia in fragile X syndrome. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:713–5.</span> [<a href="/pubmed/16924033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16924033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.neal.2006.1692">Neal J, Apse K, Sahin M, Walsh CA, Sheen VL. Deletion of chromosome 1p36 is associated with periventricular nodular heterotopia. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1692–5.</span> [<a href="/pubmed/16835933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16835933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.oegema.2013.2376">Oegema R, Hulst JM, Theuns-Valks SD, van Unen LM, Schot R, Mancini GM, Schipper ME, de Wit MC, Sibbles BJ, de Coo IF, Nanninga V, Hofstra RM, Halley DJ, Brooks AS. Novel no-stop FLNA mutation causes multi-organ involvement in males. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2376–84.</span> [<a href="/pubmed/23873601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23873601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.ott.1998.1241">Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. <span><span class="ref-journal">J Cell Biol. </span>1998;<span class="ref-vol">140</span>:1241–53.</span> [<a href="/pmc/articles/PMC2132689/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2132689</span></a>] [<a href="/pubmed/9490735" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9490735</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.parrini.2004.191">Parrini E, Mei D, Wright M, Dorn T, Guerrini R. Mosaic mutations of the FLN1 gene cause a mild phenotype in patients with periventricular heterotopia. <span><span class="ref-journal">Neurogenetics. </span>2004;<span class="ref-vol">5</span>:191–6.</span> [<a href="/pubmed/15459826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15459826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.parrini.2006.1892">Parrini E, Ramazzotti A, Dobyns WB, Mei D, Moro F, Veggiotti P, Marini C, Brilstra EH, Dalla Bernardina B, Goodwin L, Bodell A, Jones MC, Nangeroni M, Palmeri S, Said E, Sander JW, Striano P, Takahashi Y, Van Maldergem L, Leonardi G, Wright M, Walsh CA, Guerrini R. Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:1892–906.</span> [<a href="/pubmed/16684786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16684786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.poussaint.2000.748">Poussaint TY, Fox JW, Dobyns WB, Radtke R, Scheffer IE, Berkovic SF, Barnes PD, Huttenlocher PR, Walsh CA. Periventricular nodular heterotopia in patients with filamin-1 gene mutations: neuroimaging findings. <span><span class="ref-journal">Pediatr Radiol. </span>2000;<span class="ref-vol">30</span>:748–55.</span> [<a href="/pubmed/11100490" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11100490</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.reinstein.2013.494">Reinstein E, Frentz S, Morgan T, Garc&#x000ed;a-Mi&#x000f1;a&#x000fa;r S, Leventer RJ, McGillivray G, Pariani M, van der Steen A, Pope M, Holder-Espinasse M, Scott R, Thompson EM, Robertson T, Coppin B, Siegel R, Bret Zurita M, Rodr&#x000ed;guez JI, Morales C, Rodrigues Y, Arcas J, Saggar A, Horton M, Zackai E, Graham JM, Rimoin DL, Robertson SP. Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A. <span><span class="ref-journal">Eur J Hum Genet. </span>2013;<span class="ref-vol">21</span>:494–502.</span> [<a href="/pmc/articles/PMC3641385/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3641385</span></a>] [<a href="/pubmed/23032111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23032111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.robertson.2003.487">Robertson SP, Twigg SR, Sutherland-Smith AJ, Biancalana V, Gorlin RJ, Horn D, Kenwrick SJ, Kim CA, Morava E, Newbury-Ecob R, Orstavik KH, Quarrell OW, Schwartz CE, Shears DJ, Suri M, Kendrick-Jones J, Wilkie AO., OPD-spectrum Disorders Clinical Collaborative Group.  Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:487–91.</span> [<a href="/pubmed/12612583" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12612583</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.robertson.2006.1082">Robertson SP. Filamin a, periventricular nodular heterotopia, and West syndrome. <span><span class="ref-journal">Epilepsia. </span>2006;<span class="ref-vol">47</span>:1082.</span> [<a href="/pubmed/16822260" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16822260</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.sheen.2001.1775">Sheen VL, Dixon PH, Fox JW, Hong SE, Kinton L, Sisodiya SM, Duncan JS, Dubeau F, Scheffer IE, Schachter SC, Wilner A, Henchy R, Crino P, Kamuro K, DiMario F, Berg M, Kuzniecky R, Cole AJ, Bromfield E, Biber M, Schomer D, Wheless J, Silver K, Mochida GH, Berkovic SF, Andermann F, Andermann E, Dobyns WB, Wood NW, Walsh CA. Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. <span><span class="ref-journal">Hum Mol Genet. </span>2001;<span class="ref-vol">10</span>:1775–83.</span> [<a href="/pubmed/11532987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11532987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.sheen.2004.69">Sheen VL, Ganesh VS, Topcu M, Sebire G, Bodell A, Hill RS, Grant PE, Shugart YY, Imitola J, Khoury SJ, Guerrini R, Walsh CA. Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:69–76.</span> [<a href="/pubmed/14647276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14647276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.sheen.2005.254">Sheen VL, Jansen A, Chen MH, Parrini E, Morgan T, Ravenscroft R, Ganesh V, Underwood T, Wiley J, Leventer R, Vaid RR, Ruiz DE, Hutchins GM, Menasha J, Willner J, Geng Y, Gripp KW, Nicholson L, Berry-Kravis E, Bodell A, Apse K, Hill RS, Dubeau F, Andermann F, Barkovich J, Andermann E, Shugart YY, Thomas P, Viri M, Veggiotti P, Robertson S, Guerrini R, Walsh CA. Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:254–62.</span> [<a href="/pubmed/15668422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15668422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.sheen.2003a.1108">Sheen VL, Top&#x000e7;u M, Berkovic S, Yalnizoglu D, Blatt I, Bodell A, Hill RS, Ganesh VS, Cherry TJ, Shugart YY, Walsh CA. Autosomal recessive form of periventricular heterotopia. <span><span class="ref-journal">Neurology. </span>2003a;<span class="ref-vol">60</span>:1108–12.</span> [<a href="/pubmed/12682315" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12682315</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.sheen.2003b.1033">Sheen VL, Wheless JW, Bodell A, Braverman E, Cotter PD, Rauen KA, Glenn O, Weisiger K, Packman S, Walsh CA, Sherr EH. Periventricular heterotopia associated with chromosome 5p anomalies. <span><span class="ref-journal">Neurology. </span>2003b;<span class="ref-vol">60</span>:1033–6.</span> [<a href="/pubmed/12654978" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12654978</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.stahlhut.2000.325">Stahlhut M, van Deurs B. Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. <span><span class="ref-journal">Mol Biol Cell. </span>2000;<span class="ref-vol">11</span>:325–37.</span> [<a href="/pmc/articles/PMC14777/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC14777</span></a>] [<a href="/pubmed/10637311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10637311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-pvh.REF.walsh.2010.245">Walsh CA, Engle EC. Allelic diversity in human developmental neurogenetics: insights into biology and disease. <span><span class="ref-journal">Neuron. </span>2010;<span class="ref-vol">68</span>:245–53.</span> [<a href="/pmc/articles/PMC3010396/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3010396</span></a>] [<a href="/pubmed/20955932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20955932</span></a>]</div></li></ul></div></div><div id="x-pvh.Chapter_Notes"><h2 id="_x-pvh_Chapter_Notes_">Chapter Notes</h2><div id="x-pvh.Author_History"><h3>Author History</h3><p>Adria Bodell, MS, CGC; Beth Israel Deaconess Medical Center (2007-2015)<br />Ming Hui Chen, MD, MSc (2015-present)<br />Volney L Sheen, MD, PhD; Harvard Medical School (2007-2015)<br />Christopher A Walsh, MD, PhD (2007-present)</p></div><div id="x-pvh.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 September 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11/10/2014 (cw/mhc) Revision: cardiovascular added, other modifications made</div></li><li class="half_rhythm"><div>4 June 2009 (cd/cw) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available; mutation added; Differential Diagnosis edited</div></li><li class="half_rhythm"><div>10 April 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 August 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 January 2004 (cd) Revision: testing</div></li><li class="half_rhythm"><div>17 October 2003 (cw) Revision: Genetically Related Disorders</div></li><li class="half_rhythm"><div>8 October 2002 (me) Review posted live</div></li><li class="half_rhythm"><div>29 April 2002 (cw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1213</span><span class="label">PMID: <a href="/pubmed/20301392" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301392</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fkbp14-keds/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/flnb-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1213&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1213/?report=reader">PubReader</a></li><li><a href="/books/NBK1213/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1213" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1213" style="display:none" title="Cite this Page"><div class="bk_tt">Chen MH, Walsh CA. FLNA-Related Periventricular Nodular Heterotopia. 2002 Oct 8 [Updated 2015 Sep 17]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1213/pdf/Bookshelf_NBK1213.pdf">PDF version of this page</a> (263K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#x-pvh.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#x-pvh.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#x-pvh.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#x-pvh.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#x-pvh.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#x-pvh.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#x-pvh.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#x-pvh.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#x-pvh.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#x-pvh.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#x-pvh.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2316[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FLNA</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1483906" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1483906" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1483906" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1483906" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301567" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robertson S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26340046" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Phenotypic and imaging features of FLNA-negative patients with bilateral periventricular nodular heterotopia and epilepsy.</a><span class="source">[Epilepsy Behav. 2015]</span><div class="brieflinkpop offscreen_noflow">Phenotypic and imaging features of FLNA-negative patients with bilateral periventricular nodular heterotopia and epilepsy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Fallil Z, Pardoe H, Bachman R, Cunningham B, Parulkar I, Shain C, Poduri A, Knowlton R, Kuzniecky R, EPGP Investigators.. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Epilepsy Behav. 2015 Oct; 51:321-7. Epub 2015 Sep 2.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26471271" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">47 patients with FLNA associated periventricular nodular heterotopia.</a><span class="source">[Orphanet J Rare Dis. 2015]</span><div class="brieflinkpop offscreen_noflow">47 patients with FLNA associated periventricular nodular heterotopia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lange M, Kasper B, Bohring A, Rutsch F, Kluger G, Hoffjan S, Spranger S, Behnecke A, Ferbert A, Hahn A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2015 Oct 15; 10:134. Epub 2015 Oct 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301604" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">NR0B1-</i>Related Adrenal Hypoplasia Congenita</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">NR0B1-</i>Related Adrenal Hypoplasia Congenita<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Achermann JC, Vilain EJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301392" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301392" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0413bedd21425a25cb49d1">FLNA-Related Periventricular Nodular Heterotopia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">FLNA-Related Periventricular Nodular Heterotopia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:58:22-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B959CE0402421000000000711027E&amp;ncbi_session=CE8B959CE0413BD1_1809SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1213%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1213&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1213/&amp;ncbi_pagename=FLNA-Related Periventricular Nodular Heterotopia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B959CE0413BD1_1809SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>